Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms

Br J Haematol. 2009 Mar;144(6):965-7. doi: 10.1111/j.1365-2141.2008.07537.x. Epub 2008 Dec 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Age Factors
  • Case-Control Studies
  • Female
  • Humans
  • Janus Kinase 2 / genetics*
  • Male
  • Middle Aged
  • Mutation*
  • Prevalence
  • Thrombophilia / genetics
  • Venous Thromboembolism / genetics*

Substances

  • Janus Kinase 2